• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immune Monitoring Assays: Predicting Cytomegalovirus and Other Infections in Solid Organ Transplant Recipients.

作者信息

Gardiner Bradley J, Westall Glen P, Sester Martina, Torre-Cisneros Julian, Kotton Camille N

机构信息

Infectious Diseases Department, Alfred Health and Monash University, Melbourne, VIC, Australia.

Lung Transplant Service, Alfred Health and Monash University, Melbourne, VIC, Australia.

出版信息

Transplantation. 2025 Mar 1;109(3):395-398. doi: 10.1097/TP.0000000000005218. Epub 2024 Oct 1.

DOI:10.1097/TP.0000000000005218
PMID:39968631
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11834956/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd48/11834956/e79e0c6d509b/tpa-109-395-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd48/11834956/e79e0c6d509b/tpa-109-395-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd48/11834956/e79e0c6d509b/tpa-109-395-g001.jpg

相似文献

1
Immune Monitoring Assays: Predicting Cytomegalovirus and Other Infections in Solid Organ Transplant Recipients.免疫监测检测：预测实体器官移植受者中的巨细胞病毒及其他感染
Transplantation. 2025 Mar 1;109(3):395-398. doi: 10.1097/TP.0000000000005218. Epub 2024 Oct 1.
2
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.分子诊断时代欧洲各中心实体器官移植受者巨细胞病毒感染的管理：一项欧洲移植感染和临床微生物学会调查
Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12773. Epub 2017 Oct 25.
3
Immune Control of Human Cytomegalovirus (HCMV) Infection in HCMV-Seropositive Solid Organ Transplant Recipients: The Predictive Role of Different Immunological Assays.人类巨细胞病毒（HCMV）感染的免疫控制：在 HCMV 血清阳性实体器官移植受者中的作用：不同免疫测定的预测作用。
Cells. 2024 Aug 8;13(16):1325. doi: 10.3390/cells13161325.
4
Advancing cytomegalovirus prevention in solid organ transplant recipients: The promise of cell-mediated immune assays.推进实体器官移植受者巨细胞病毒预防：细胞介导免疫检测的前景。
Transpl Infect Dis. 2024 Apr;26(2):e14245. doi: 10.1111/tid.14245. Epub 2024 Jan 31.
5
Clinical utility of cytomegalovirus viral load in solid organ transplant recipients.巨细胞病毒载量在实体器官移植受者中的临床应用价值
Curr Opin Infect Dis. 2015 Aug;28(4):317-22. doi: 10.1097/QCO.0000000000000173.
6
Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial.免疫监测指导与固定疗程抗病毒预防治疗实体器官移植受者巨细胞病毒感染：一项多中心、随机临床试验。
Clin Infect Dis. 2024 Feb 17;78(2):312-323. doi: 10.1093/cid/ciad575.
7
Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.实体器官移植受者巨细胞病毒感染：美国移植感染病学会实践社区指南。
Clin Transplant. 2019 Sep;33(9):e13512. doi: 10.1111/ctr.13512. Epub 2019 Mar 28.
8
Interleukin-18 and tumor necrosis factor-α are elevated in solid organ transplant recipients with possible cytomegalovirus end-organ disease.白细胞介素-18 和肿瘤坏死因子-α 在实体器官移植受者中升高，可能伴有巨细胞病毒终末器官疾病。
Transpl Infect Dis. 2021 Aug;23(4):e13682. doi: 10.1111/tid.13682. Epub 2021 Jul 16.
9
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.对巨细胞病毒血症进行抢先治疗以预防实体器官移植受者的巨细胞病毒疾病。
Cochrane Database Syst Rev. 2025 Jan 14;1(1):CD005133. doi: 10.1002/14651858.CD005133.pub4.
10
Cytomegalovirus Infection After Solid Organ Transplantation: How I Use Cell-Mediated Immune Assays for Management.器官移植后巨细胞病毒感染：我如何使用细胞介导免疫测定进行管理。
Viruses. 2024 Nov 15;16(11):1781. doi: 10.3390/v16111781.

引用本文的文献

1
Use of the QuantiFERON Monitor Assay to Predict Clinical Outcomes in Solid Organ and Hematopoietic Cell Transplant Recipients: A Scoping Review.使用QuantiFERON监测检测法预测实体器官和造血细胞移植受者的临床结局：一项范围综述
Transpl Infect Dis. 2025 Jul 1;27(4):e70074. doi: 10.1111/tid.70074.

本文引用的文献

1
Cytomegalovirus Cell-Mediated Immunity: Ready for Routine Use?巨细胞病毒细胞介导免疫：准备好常规应用了吗？
Transpl Int. 2023 Nov 7;36:11963. doi: 10.3389/ti.2023.11963. eCollection 2023.
2
QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients.巨细胞病毒（CMV）定量-干扰素-CMV 作为 CMV 血清阳性肾移植受者抢先治疗期间 CMV 事件的预测指标。
Transplantation. 2024 Apr 1;108(4):985-995. doi: 10.1097/TP.0000000000004870. Epub 2023 Nov 22.
3
Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial.
免疫监测指导与固定疗程抗病毒预防治疗实体器官移植受者巨细胞病毒感染：一项多中心、随机临床试验。
Clin Infect Dis. 2024 Feb 17;78(2):312-323. doi: 10.1093/cid/ciad575.
4
Kinetics of Torque Teno Virus Viral Load Is Associated with Infection and De Novo Donor Specific Antibodies in the First Year after Kidney Transplantation: A Prospective Cohort Study.肾移植后第一年的扭结纤维瘤病毒载量动力学与感染和新的供体特异性抗体有关：一项前瞻性队列研究。
Viruses. 2023 Jun 28;15(7):1464. doi: 10.3390/v15071464.
5
Torque teno virus load as marker of rejection and infection in solid organ transplantation - A systematic review and meta-analysis.Torque teno 病毒载量作为实体器官移植中排斥和感染的标志物：系统评价和荟萃分析。
Rev Med Virol. 2023 Jan;33(1):e2393. doi: 10.1002/rmv.2393. Epub 2022 Sep 3.
6
Utility of Cytomegalovirus Cell-Mediated Immunity Assays in Solid Organ Transplantation.巨细胞病毒细胞介导免疫测定在实体器官移植中的应用。
J Clin Microbiol. 2022 Aug 17;60(8):e0171621. doi: 10.1128/jcm.01716-21. Epub 2022 May 11.
7
Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial.免疫指导下停用抗胸腺细胞球蛋白治疗的肾移植受者巨细胞病毒病的预防：一项随机临床试验。
Clin Infect Dis. 2022 Mar 9;74(5):757-765. doi: 10.1093/cid/ciab574.
8
Evaluation of Quantiferon®-Monitor as a biomarker of immunosuppression and predictor of infection in lung transplant recipients.评价 Quantiferon®-Monitor 作为肺移植受者免疫抑制的生物标志物和感染预测因子。
Transpl Infect Dis. 2021 Jun;23(3):e13550. doi: 10.1111/tid.13550. Epub 2021 Jan 5.
9
Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the "Net State of Immunosuppression".免疫抑制剂与移植感染风险：管理“免疫抑制净状态”。
Clin Infect Dis. 2021 Oct 5;73(7):e1302-e1317. doi: 10.1093/cid/ciaa1189.
10
A Polyclonal Immune Function Assay Allows Dose-Dependent Characterization of Immunosuppressive Drug Effects but Has Limited Clinical Utility for Predicting Infection on an Individual Basis.多克隆免疫功能检测可用于剂量依赖性评估免疫抑制药物的作用，但在预测个体感染方面的临床应用有限。
Front Immunol. 2020 May 15;11:916. doi: 10.3389/fimmu.2020.00916. eCollection 2020.